Analysed RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) News Sources
Recursion Pharmaceuticals (RXRX) Stock Sees Modest Fair Value Lift After Analyst Target Revisions
19-10-2026
yahoo.com
Why Recursion Pharmaceuticals Stock Is In Focus After Drug Data And Sanofi Milestone
19-10-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Surpasses Market Returns: Some Facts Worth Knowing
20-10-2026
yahoo.com
Recursion to Host Webinar Focused on Updated REC-4881 (FAP) Data from CGA-IGC on Tuesday, November 3
26-10-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to Consider
26-10-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
28-10-2026
yahoo.com
Absci Sinks 8%, Schrödinger and Recursion Slide as AI Drug Discovery Stocks Give Back Rally
30-10-2026
tikr.com
What is the current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is $4.03.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is $-0.21.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is -4.9528%.
What is the most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is .
SEC-8K** Filing Available For RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.